Amgen
Catherine Davis, MD, is an experienced oncologist currently serving as the Executive Director of Clinical Development at Amgen since November 2017. With a strong background in oncology clinical development and medical affairs, Catherine has also been the President of Davis Consulting since July 2011. Prior roles include Director of Medical Affairs Oncology at AstraZeneca from April 2008 to July 2011, Associate Medical Director at Bristol-Myers Squibb from April 2006 to April 2008, and a decade in private oncology practice from June 1996 to April 2006. Catherine's education includes an MD in Medicine from the Mayo Clinic (1993-1996) and earlier studies at Cornell University (BA, Pre-Med and Government, 1987-1990) and Columbia University.
This person is not in any offices
Amgen
280 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.